Cargando…
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
Polycystic ovarian syndrome (PCOS) is the most common endocrinological disorder in women, in which, besides chronic anovulation/oligomenorrhea and ovarian cysts, hyperandrogenism plays a critical role in a large fraction of subjects. Inositol isomers—myo-Inositol and D-Chiro-Inositol—have recently b...
Autores principales: | Fedeli, Valeria, Catizone, Angela, Querqui, Alessandro, Unfer, Vittorio, Bizzarri, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093919/ https://www.ncbi.nlm.nih.gov/pubmed/37047265 http://dx.doi.org/10.3390/ijms24076296 |
Ejemplares similares
-
Myo-Inositol Reverses TGF-β1-Induced EMT in MCF-10A Non-Tumorigenic Breast Cells
por: Monti, Noemi, et al.
Publicado: (2023) -
Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
por: Unfer, Vittorio, et al.
Publicado: (2023) -
Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS
por: Unfer, Vittorio, et al.
Publicado: (2020) -
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021) -
A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
por: Unfer, Vittorio, et al.
Publicado: (2023)